Immediate Impact

2 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

Cefepime–Taniborbactam in Complicated Urinary Tract Infection
2024 Standout
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
2 intermediate papers

Works of Greg Stone being referenced

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
2016
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
2016

Author Peers

Author Last Decade Papers Cites
Greg Stone 406 523 58 270 7 697
Michael A. Zhanel 362 578 105 267 10 823
Anthony M. Nicasio 590 468 72 366 17 764
Courtney K. Lawrence 343 540 92 200 11 752
G. Poulakou 417 603 65 345 10 762
Jiejun Du 384 495 126 269 21 725
Dimitris Goukos 271 416 31 242 14 676
Konstantinos Pontikis 427 567 68 331 20 714
Obiamiwe Umeh 395 451 35 288 9 592
Athina Argyrοpoulou 319 498 127 246 15 706
Brian Nelson 263 390 148 220 16 644

All Works

Loading papers...

Rankless by CCL
2026